GF Fund Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.2K Buy
1,775
+222
+14% +$8.22K ﹤0.01% 386
2025
Q4
$65.4K Sell
1,553
-140
-8% -$5.64K ﹤0.01% 384
2025
Q3
$58.1K Sell
1,693
-291
-15% -$8.35K ﹤0.01% 378
2025
Q2
$53.6K Hold
1,984
﹤0.01% 409
2025
Q1
$58.8K Buy
1,984
+357
+22% +$13.6K ﹤0.01% 405
2024
Q4
$64.4K Buy
+1,627
New +$61.6K ﹤0.01% 364

Other funds holding VCYT

GF Fund Management's VCYT Position: Q1 2026 in Review

GF Fund Management increased its Veracyte (VCYT) stake by 14% in Q1 2026, buying an estimated $8.22K and bringing the position to 1,775 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

GF Fund Management first reported a position in VCYT in Q4 2024 and has held it in 6 quarters since. The position peaked at $65.4K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • GF Fund Management held 1,775 shares of Veracyte worth $57.2K as of Q1 2026.
  • GF Fund Management bought 222 Veracyte shares in Q1 2026, an estimated $8.22K.
  • Veracyte made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #386 holding.
  • GF Fund Management first reported a position in Veracyte in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Veracyte position peaked at $65.4K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.